NCT00244998View on ClinicalTrials.gov

Fulvestrant in Treating Patients With Advanced Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

June 30, 2012

Conditions
Prostate Cancer
Interventions
DRUG

fulvestrant

IM

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00244998 - Fulvestrant in Treating Patients With Advanced Prostate Cancer | Biotech Hunter | Biotech Hunter